Streamline Payroll in 2026! ezPaycheck Software Designed for Small Business and Accountant’s Success

Halfpricesoft, the provider of innovative and affordable software solutions, is thrilled to announce the launch of ezPaycheck 2026, the ultimate payroll solution designed to empower small businesses and accountants, alike. Try it free at halfpricesoft.com ezPaycheck 2026 is hot off the presses for both new and returning clients!Running payroll can be a daunting and time-consuming

Securities Fraud Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) – Levi & Korsinsky Reminds Investors of January 9, 2026

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to explore

Recover Investment Losses: Class Action Initiated Against Firefly Aerospace Inc. (FLY)

NEW YORK, NY / ACCESS Newswire / December 29, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Firefly Aerospace Inc. (NASDAQ:FLY) securities. If you suffered a loss on your Firefly Aerospace Inc. investment and would like to explore

Shanghai unveils steps to build sci-tech innovation corridor in Yangtze River Delta

A news report from english.shanghai.gov.cn https://mma.prnewswire.com/media/2852270/sci.jpg The Shanghai Municipal Government issued measures to support the construction of the G60 science and technology innovation corridor in the Yangtze River Delta as a source area on Dec 25, making the corridor a pioneer in China's scientific and technological and industrial innovation. The measures highlight the functional positioning

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type 1 diabetes from 24 to 15 months, per FDA guidance, enabling the full primary efficacy readout of the trial to occur nine months earlier than

Synopsys, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – SNPS

The DJS Law Group reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys ” or “the Company”) (NASDAQ: SNPS ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SNPS during the class

Gauzy Ltd. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – GAUZ

The DJS Law Group reminds investors of a class action lawsuit against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ: GAUZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of GAUZ during the class period

Scroll to Top